90 related articles for article (PubMed ID: 413872)
1. Detection of immune complex-like materials in cancer patients' sera: a comparative study of results obtained with the C1q deviation and C1q binding tests.
Rossen RD; Zubler RH; Day NK; Reisberg MA; Morgan AC; Gutterman JU; Hersh EM
J Lab Clin Med; 1978 Feb; 91(2):191-204. PubMed ID: 413872
[TBL] [Abstract][Full Text] [Related]
2. A comparison of two 125I C1q binding tests to detect soluble immune complexes in serum of patients with malignant disease.
Shepherd PS
Clin Exp Immunol; 1979 May; 36(2):250-5. PubMed ID: 477028
[TBL] [Abstract][Full Text] [Related]
3. Critical aspects of the 125I-C1q binding assay for detecting immune complexes in tumor patients.
Krieger G; Bause I; Kneba M; Kehl A; Nagel GA
J Clin Lab Immunol; 1984 Jun; 14(2):87-92. PubMed ID: 6611419
[TBL] [Abstract][Full Text] [Related]
4. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.
Hardin JA; Walker LC; Steere AC; Trumble TC; Tung KS; Williams RC; Ruddy S; Malawista SE
J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566
[TBL] [Abstract][Full Text] [Related]
5. C1q binding substances in pemphigus and bullous pemphigoid. Detection with a [131I] C1q binding assay.
Tappeiner G; Heine KG; Kahl JC; Jordon RE
Clin Exp Immunol; 1977 Apr; 28(1):40-8. PubMed ID: 324678
[TBL] [Abstract][Full Text] [Related]
6. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
Kilgallon W; Amlot PL; Williams BD
Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
[TBL] [Abstract][Full Text] [Related]
7. Circulating immune complexes and tumor cell cytotoxins as prognostic indicators in malignant melanoma: a prospective study of 53 patients.
Rossen RD; Crane MM; Morgan AC; Giannini EH; Giovanella BC; Stehlin JS; Twomey JJ; Hersh EM
Cancer Res; 1983 Jan; 43(1):422-9. PubMed ID: 6600161
[TBL] [Abstract][Full Text] [Related]
8. [Detection of circulating immune complexes by the C1q complement fraction deviation test. 1st application in the study of human glomerulopathies].
Sobel A; Gabay Y; Lagrue G
Nouv Presse Med; 1976 Jun; 5(23):1465-9. PubMed ID: 132639
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
Mooney NA; Hay FC; Poulton TA
Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
[TBL] [Abstract][Full Text] [Related]
10. Circulating immune complexes detected by 125I-Clq deviation test in sera of cancer patients.
Teshima H; Wanebo H; Pinsky C; Day NK
J Clin Invest; 1977 Jun; 59(6):1134-42. PubMed ID: 325016
[TBL] [Abstract][Full Text] [Related]
11. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
[TBL] [Abstract][Full Text] [Related]
12. C1q binding activity in the sera of patients with chronic lung diseases.
Cooper KM; Moore M; Hilton AM
Clin Exp Immunol; 1981 Jul; 45(1):18-28. PubMed ID: 6975678
[TBL] [Abstract][Full Text] [Related]
13. Serial measurement of circulating immune complexes in the sera of patients with leukaemia.
Mód A; Carpentier N; Füst G; Lambert PH; Miescher P; Hollán SR
J Clin Lab Immunol; 1980 Jul; 4(1):15-20. PubMed ID: 7007648
[TBL] [Abstract][Full Text] [Related]
14. [Immune complexes in the serum of patients with acute myeloblastic leukemia].
Späth P; Berchtold P; Engler H; Bütler R
Schweiz Med Wochenschr; 1984 Oct; 114(40):1373-5. PubMed ID: 6593823
[TBL] [Abstract][Full Text] [Related]
15. Further evidence against preeclampsia as an immune complex disease.
Balasch J; Mirapeix E; Borche L; Vives J; González-Merlo J
Obstet Gynecol; 1981 Oct; 58(4):435-7. PubMed ID: 6456434
[TBL] [Abstract][Full Text] [Related]
16. Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases.
Van Dijk H; Van Voorst J; Jankowski IG; Imhof JW; Kerckhaert JA
Clin Exp Immunol; 1984 Aug; 57(2):495-501. PubMed ID: 6432386
[TBL] [Abstract][Full Text] [Related]
17. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
Tas SW; Klickstein LB; Barbashov SF; Nicholson-Weller A
J Immunol; 1999 Nov; 163(9):5056-63. PubMed ID: 10528211
[TBL] [Abstract][Full Text] [Related]
18. Characterization of immune complexes and immunoglobulin G antibodies reactive with neutrophils in the sera of patients with Felty's syndrome.
Starkebaum G; Arend WP; Nardella FA; Gavin SE
J Lab Clin Med; 1980 Aug; 96(2):238-51. PubMed ID: 6772719
[TBL] [Abstract][Full Text] [Related]
19. Absence of a binding reactivity of human C-reactive protein for immunoglobulin or immune complexes.
Ballou SP; Macintyre SS
J Lab Clin Med; 1990 Mar; 115(3):332-8. PubMed ID: 2107267
[TBL] [Abstract][Full Text] [Related]
20. Purification of soluble immune complexes from serum using polymethylmetacrylate beads coated with conglutinin or C1q. Application to the analysis of the components of in vitro formed immune complexes and of immune complexes occurring in vivo during leishmaniasis.
Casali P; Lambert PH
Clin Exp Immunol; 1979 Aug; 37(2):295-309. PubMed ID: 498587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
